OPCH Quote, Financials, Valuation and Earnings

Chemed Corp. has a net margin of 3.61% compared to Option Care Health, Inc.'s net margin of 10.28%. Option Care Health, Inc.'s return on equity of 15.16% beat Chemed Corp.'s return on equity of 23.99%.

Option Care Health, Inc. has a consensus price target of $37.91, signalling upside risk potential of 3.61%. On the other hand Chemed Corp. has an analysts' consensus of $555.50 which suggests that it could grow by 24.9%. Given that Chemed Corp. has higher upside potential than Option Care Health, Inc., analysts believe Chemed Corp. is more attractive than Option Care Health, Inc..

Option Care Health, Inc. has a beta of 0.804, which suggesting that the stock is 19.571% less volatile than S&P 500. In comparison Chemed Corp. has a beta of 0.443, suggesting its less volatile than the S&P 500 by 55.685%.

Option Care Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Chemed Corp. offers a yield of 0.5% to investors and pays a quarterly dividend of $0.60 per share. Option Care Health, Inc. pays -- of its earnings as a dividend. Chemed Corp. pays out 9.05% of its earnings as a dividend. Chemed Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Option Care Health, Inc. quarterly revenues are $1.4B, which are larger than Chemed Corp. quarterly revenues of $624.9M. Option Care Health, Inc.'s net income of $51.8M is lower than Chemed Corp.'s net income of $64.2M. Notably, Option Care Health, Inc.'s price-to-earnings ratio is 29.05x while Chemed Corp.'s PE ratio is 23.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health, Inc. is 1.10x versus 2.59x for Chemed Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Health Catalyst, Inc. has a net margin of 3.61% compared to Option Care Health, Inc.'s net margin of -29.13%. Option Care Health, Inc.'s return on equity of 15.16% beat Health Catalyst, Inc.'s return on equity of -30.29%.

Option Care Health, Inc. has a consensus price target of $37.91, signalling upside risk potential of 3.61%. On the other hand Health Catalyst, Inc. has an analysts' consensus of $3.88 which suggests that it could grow by 64.2%. Given that Health Catalyst, Inc. has higher upside potential than Option Care Health, Inc., analysts believe Health Catalyst, Inc. is more attractive than Option Care Health, Inc..

Option Care Health, Inc. has a beta of 0.804, which suggesting that the stock is 19.571% less volatile than S&P 500. In comparison Health Catalyst, Inc. has a beta of 1.690, suggesting its more volatile than the S&P 500 by 69.042%.

Option Care Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Health Catalyst, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health, Inc. pays -- of its earnings as a dividend. Health Catalyst, Inc. pays out -- of its earnings as a dividend.

Option Care Health, Inc. quarterly revenues are $1.4B, which are larger than Health Catalyst, Inc. quarterly revenues of $76.3M. Option Care Health, Inc.'s net income of $51.8M is higher than Health Catalyst, Inc.'s net income of -$22.2M. Notably, Option Care Health, Inc.'s price-to-earnings ratio is 29.05x while Health Catalyst, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health, Inc. is 1.10x versus 0.51x for Health Catalyst, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of 3.61% compared to Option Care Health, Inc.'s net margin of 0.59%. Option Care Health, Inc.'s return on equity of 15.16% beat Humana, Inc.'s return on equity of 7.3%.

Option Care Health, Inc. has a consensus price target of $37.91, signalling upside risk potential of 3.61%. On the other hand Humana, Inc. has an analysts' consensus of $288.42 which suggests that it could grow by 8.31%. Given that Humana, Inc. has higher upside potential than Option Care Health, Inc., analysts believe Humana, Inc. is more attractive than Option Care Health, Inc..

Option Care Health, Inc. has a beta of 0.804, which suggesting that the stock is 19.571% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.452, suggesting its less volatile than the S&P 500 by 54.811%.

Option Care Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.33% to investors and pays a quarterly dividend of $0.89 per share. Option Care Health, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 35.45% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Option Care Health, Inc. quarterly revenues are $1.4B, which are smaller than Humana, Inc. quarterly revenues of $32.6B. Option Care Health, Inc.'s net income of $51.8M is lower than Humana, Inc.'s net income of $194M. Notably, Option Care Health, Inc.'s price-to-earnings ratio is 29.05x while Humana, Inc.'s PE ratio is 24.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health, Inc. is 1.10x versus 0.25x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx Corp. has a net margin of 3.61% compared to Option Care Health, Inc.'s net margin of 2.99%. Option Care Health, Inc.'s return on equity of 15.16% beat OptimizeRx Corp.'s return on equity of 0.03%.

Option Care Health, Inc. has a consensus price target of $37.91, signalling upside risk potential of 3.61%. On the other hand OptimizeRx Corp. has an analysts' consensus of $24.33 which suggests that it could grow by 103.46%. Given that OptimizeRx Corp. has higher upside potential than Option Care Health, Inc., analysts believe OptimizeRx Corp. is more attractive than Option Care Health, Inc..

Option Care Health, Inc. has a beta of 0.804, which suggesting that the stock is 19.571% less volatile than S&P 500. In comparison OptimizeRx Corp. has a beta of 1.087, suggesting its more volatile than the S&P 500 by 8.711%.

Option Care Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Option Care Health, Inc. pays -- of its earnings as a dividend. OptimizeRx Corp. pays out -- of its earnings as a dividend.

Option Care Health, Inc. quarterly revenues are $1.4B, which are larger than OptimizeRx Corp. quarterly revenues of $26.1M. Option Care Health, Inc.'s net income of $51.8M is higher than OptimizeRx Corp.'s net income of $779K. Notably, Option Care Health, Inc.'s price-to-earnings ratio is 29.05x while OptimizeRx Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Option Care Health, Inc. is 1.10x versus 2.06x for OptimizeRx Corp.. Usually stocks with elevated PS ratios are considered overvalued.